Single-cell virus sequencing of influenza infections that trigger innate immunity

Journal of Virology

Volumn 93, Issue 14, 2019, Pages

  Russell, Alistair B ^a   Elshina, Elizaveta ^b   Kowalsky, Jacob R ^a   te Velthuis, Aartjan J W ^b   Blooma, Jesse D ^c,d  

^a USA   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

10x Chromium; Defective virus; Heterogeneity; Influenza virus; Interferon; NS1; PacBio; PB1; Single cell RNA seq

Indexed keywords

INS1 PROTEIN, INFLUENZA VIRUS; VIRAL PROTEIN;

A-549 CELL LINE; GENETIC VARIATION; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INNATE IMMUNITY; SEQUENCE ANALYSIS; SINGLE CELL ANALYSIS;

A549 CELLS; GENETIC VARIATION; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; SEQUENCE ANALYSIS, RNA; SINGLE-CELL ANALYSIS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 85069237924     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00500-19     Document Type: Article

References (97)

1. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25:373–381. https://doi.org/10.1016/j.immuni.2006.08.007.
2. Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349–360. https://doi.org/10.1016/j.immuni.2006.08.009.
3. Solov’ev V. 1969. The results of controlled observations on the prophylaxis of influenza with interferon. Bull World Health Organ 41:683–688.
4. Treanor JJ, Betts RF, Erb SM, Roth FK, Dolin R. 1987. Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans. J Infect Dis 156:379–383. https://doi.org/10.1093/infdis/156.2.379.
5. Beilharz MW, Cummins JM, Bennett AL. 2007. Protection from lethal influenza virus challenge by oral type 1 interferon. Biochem Biophys Res Commun 355:740–744. https://doi.org/10.1016/j.bbrc.2007.02.019.
6. Kugel D, Kochs G, Obojes K, Roth J, Kobinger GP, Kobasa D, Haller O, Staeheli P, Von Messling V. 2009. Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol 83:3843–3851. https://doi.org/10.1128/JVI.02453-08.
7. Steel J, Staeheli P, Mubareka S, Garcia-Sastre A, Palese P, Lowen AC. 2010. Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol 84: 21–26. https://doi.org/10.1128/JVI.01732-09.
8. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. 2007. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85:85–92. https://doi.org/10.1038/sj.icb.7100026.
9. Iwasaki A, Pillai PS. 2014. Innate immunity to influenza virus infection. Nat Rev Immunol 14:315. https://doi.org/10.1038/nri3665.
10. Kallfass C, Lienenklaus S, Weiss S, Staeheli P. 2013. Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. J Virol 87:6925–6930. https://doi.org/10.1128/JVI.00283-13.
11. Killip MJ, Jackson D, Perez-Cidoncha M, Fodor E, Randall RE. 2017. Single-cell studies of IFN-β promoter activation by wild-type and NS1-defective influenza A viruses. J Gen Virol 98:357–363. https://doi.org/10.1099/jgv.0.000687.
12. Russell AB, Trapnell C, Bloom JD. 2018. Extreme heterogeneity of influenza virus infection in single cells. Elife 7:e32303. https://doi.org/10.7554/eLife.32303.
13. Steuerman Y, Cohen M, Peshes-Yaloz N, Valadarsky L, Cohn O, David E, Frishberg A, Mayo L, Bacharach E, Amit I, Gat-Viks I. 2018. Dissection of influenza infection in vivo by single-cell RNA sequencing. Cell Syst 6:679.e4–691.e4. https://doi.org/10.1016/j.cels.2018.05.008.
14. Sjaastad LE, Fay EJ, Fiege JK, Macchietto MG, Stone IA, Markman MW, Shen S, Langlois RA. 2018. Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo. Proc Natl Acad Sci U S A 115:9610–9615. https://doi.org/10.1073/pnas .1807516115.
15. Heldt FS, Kupke SY, Dorl S, Reichl U, Frensing T. 2015. Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection. Nat Commun 6:8938. https://doi.org/10.1038/ncomms9938.
16. Wang C, Forst CV, Chou T, Geber A, Wang M, Hamou W, Smith M, Sebra R, Zhang B, Zhou B, Ghedin E. 2018. Cell-to-cell variation in defective virus expression and effects on host responses during influenza virus infection. bioRxiv https://doi.org/10.1101/487785.
17. McCrone JT, Woods RJ, Martin ET, Malosh RE, Monto AS, Lauring AS. 2018. Stochastic processes constrain the within and between host evolution of influenza virus. Elife 7:e35962. https://doi.org/10.7554/eLife.35962.
18. Xue KS, Bloom JD. 25 February 2019. Reconciling disparate estimates of viral genetic diversity during human influenza infections. Nat Genet https://doi.org/10.1038/s41588-019-0349-3.
19. Varble A, Albrecht RA, Backes S, Crumiller M, Bouvier NM, Sachs D, Garcia-Sastre A, tenOever BR. 2014. Influenza A virus transmission bottlenecks are defined by infection route and recipient host. Cell Host Microbe 16:691–700. https://doi.org/10.1016/j.chom.2014.09.020.
20. Shalek AK, Satija R, Adiconis X, Gertner RS, Gaublomme JT, Raychowdhury R, Schwartz S, Yosef N, Malboeuf C, Lu D, Trombetta JJ, Gennert D, Gnirke A, Goren A, Hacohen N, Levin JZ, Park H, Regev A. 2013. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature 498:236 –241. https://doi.org/10.1038/ nature12172.
21. Shalek AK, Satija R, Shuga J, Trombetta JJ, Gennert D, Lu D, Chen P, Gertner RS, Gaublomme JT, Yosef N, Schwartz S, Fowler B, Weaver S, Wang J, Wang X, Ding R, Raychowdhury R, Friedman N, Hacohen N, Park H, May AP, Regev A. 2014. Single cell RNA Seq reveals dynamic paracrine control of cellular variation. Nature 510:363. https://doi.org/10.1038/ nature13437.
22. Wimmers F, Subedi N, van Buuringen N, Heister D, Vivie J, Beeren-Reinieren I, Woestenenk R, Dolstra H, Piruska A, Jacobs JF, van Oudenaarden A, Figdor CG, Huck WTS, de Vries JM, Tel J. 2018. Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells. Nat Commun 9:3317. https://doi.org/10.1038/s41467-018-05784-3.
23. Bhushal S, Wolfsmuller M, Selvakumar T, Kemper L, Wirth D, Hornef M, Hauser H, Koster M. 2017. Cell polarization and epigenetic status shape the heterogeneous response to type III interferons in intestinal epithelial cells. Front Immunol 8:671– 671. https://doi.org/10.3389/fimmu.2017 .00671.
24. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330. https://doi.org/10.1006/viro.1998.9508.
25. Hale BG, Randall RE, Ortin J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359–2376. https://doi.org/10.1099/vir.0.2008/004606-0.
26. Hayashi T, MacDonald LA, Takimoto T. 2015. Influenza A virus protein PA-X contributes to viral growth and suppression of the host antiviral and immune responses. J Virol 89:6442–6452. https://doi.org/10.1128/JVI.00319-15.
27. Vreede FT, Chan AY, Sharps J, Fodor E. 2010. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells. Virology 396:125–134. https://doi.org/10.1016/j.virol.2009.10.003.
28. Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, Wixler V, Ludwig S. 2011. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem 392:1135–1144. https://doi.org/10.1515/BC.2011.174.
29. Killip MJ, Fodor E, Randall RE. 2015. Influenza virus activation of the interferon system. Virus Res 209:11–22. https://doi.org/10.1016/j.virusres.2015.02.003.
30. Parvin JD, Moscona A, Pan W, Leider J, Palese P. 1986. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type. J Virol 59:377–383.
31. Suarez P, Valcarcel J, Ortin J. 1992. Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants. J Virol 66: 2491–2494.
32. Suarez-Lopez P, Ortin J. 1994. An estimation of the nucleotide substitution rate at defined positions in the influenza virus haemagglutinin gene. J Gen Virol 75:389–393. https://doi.org/10.1099/0022-1317-75-2 -389.
33. Bloom JD. 2014. An experimentally determined evolutionary model dramatically improves phylogenetic fit. Mol Biol Evol 31:1956–1978. https://doi.org/10.1093/molbev/msu173.
34. Pauly MD, Procario MC, Lauring AS. 2017. A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses. Elife 6:e26437. https://doi.org/10.7554/eLife.26437.
35. te Velthuis A, Long J, Bauer DL, Fan R, Yen HL, Sharps J, Siegers J, Killip M, French H, Oliva-Martin MJ, Randall R, de Wit E, van Riel D, Poon L, Fodor E. 2018. Mini viral RNAs act as innate immune agonists during influenza virus infection. Nat Microbiol 3:1234–1242. https://doi.org/10.1038/s41564-018-0240-5.
36. Du Y, Xin L, Shi Y, Zhang TH, Wu NC, Dai L, Gong D, Brar G, Shu S, Luo J, Reiley W, Tseng YW, Bai H, Wu TT, Wang J, Shu Y, Sun R. 2018. Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design. Science 359:290–296. https://doi.org/10.1126/science.aan8806.
37. Pérez-Cidoncha M, Killip MJ, Oliveros JC, Asensio VJ, Fernández Y, Bengoechea JA, Randall RE, Ortín J. 2014. An unbiased genetic screen reveals the polygenic nature of the influenza virus anti-interferon response. J Virol 88:4632–4646. https://doi.org/10.1128/JVI.00014-14.
38. Baum A, Sachidanandam R, Garcia-Sastre A. 2010. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 107:16303–16308. https://doi.org/10.1073/pnas.1005077107.
39. Tapia K, Kim W-K, Sun Y, Mercado-López X, Dunay E, Wise M, Adu M, López CB. 2013. Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog 9:e1003703. https://doi.org/10.1371/journal.ppat.1003703.
40. Boergeling Y, Rozhdestvensky TS, Schmolke M, Resa-Infante P, Robeck T, Randau G, Wolff T, Gabriel G, Brosius J, Ludwig S. 2015. Evidence for a novel mechanism of influenza virus-induced type I interferon expression by a defective RNA-encoded protein. PLoS Pathog 11:e1004924. https://doi.org/10.1371/journal.ppat.1004924.
41. Dimmock NJ, Easton AJ. 2015. Cloned defective interfering influenza RNA and a possible pan-specific treatment of respiratory virus diseases. Viruses 7:3768–3788. https://doi.org/10.3390/v7072796.
42. Liu G, Lu Y, Liu Q, Zhou Y. 2019. Inhibition of ongoing influenza A virus replication reveals different mechanisms of RIG-I activation. J Virol 93: e02066-18. https://doi.org/10.1128/JVI.02066-18.
43. Brooke CB, Ince WL, Wrammert J, Ahmed R, Wilson PC, Bennink JR, Yewdell JW. 2013. Most influenza A virions fail to express at least one essential viral protein. J Virol 87:3155–3162. https://doi.org/10.1128/JVI .02284-12.
44. Guo F, Li S, Caglar MU, Mao Z, Liu W, Woodman A, Arnold JJ, Wilke CO, Huang TJ, Cameron CE. 2017. Single-cell virology: on-chip investigation of viral infection dynamics. Cell Rep 21:1692–1704. https://doi.org/10.1016/j.celrep.2017.10.051.
45. Zanini F, Pu SY, Bekerman E, Einav S, Quake SR. 2018. Single-cell transcriptional dynamics of flavivirus infection. Elife 7:e32942. https://doi.org/10.7554/eLife.32942.
46. Zanini F, Robinson M, Croote D, Sahoo MK, Sanz AM, Ortiz-Lasso E, Albornoz LL, Suarez FR, Montoya JG, Pinsky BA, Quake S, Einav S. 2018. Virus-inclusive single-cell RNA sequencing reveals molecular signature predictive of progression to severe dengue infection. Proc Natl Acad Sci U S A 115:E12363–E12369. https://doi.org/10.1073/pnas.1813819115.
47. Saikia M, Burnham P, Keshavjee SH, Wang MF, Heyang M, Moral-Lopez P, Hinchman MM, Danko CG, Parker JS, De Vlaminck I. 2019. Simultaneous multiplexed amplicon sequencing and transcriptome profiling in single cells. Nat Methods 16:59–62. https://doi.org/10.1038/s41592-018-0259-9.
48. O’Neal JT, Upadhyay AA, Wolabaugh A, Patel NB, Bosinger SE, Suthar MS. 2019. West Nile virus-inclusive single-cell RNA sequencing reveals heterogeneity in the type I interferon response within single cells. J Virol 93:e01778-18. https://doi.org/10.1128/JVI.01778-18.
49. Russell AB, Kowalsky JR, Bloom JD. 2018. Single-cell virus sequencing of influenza infections that trigger innate immunity. bioRxiv https://doi.org/10.1101/437277.
50. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C. 1997. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus leukemia. Science 276:1719 –1724. https://doi.org/10.1126/science.276.5319.1719.
51. Ruggieri L, Aiuti A, Salomoni M, Zappone E, Ferrari G, Bordignon C. 1997. Cell-surface marking of CD34-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum Gene Ther 8:1611–1623. https://doi.org/10.1089/hum.1997.8.13-1611.
52. Strahle L, Garcin D, Kolakofsky D. 2006. Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 351:101–111. https://doi.org/10.1016/j.virol.2006.03.022.
53. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97:6108–6113. https://doi.org/10.1073/pnas.100133697.
54. Xue J, Chambers BS, Hensley SE, Lopez CB. 2016. Propagation and characterization of influenza virus stocks that lack high levels of defective viral genomes and hemagglutinin mutations. Front Microbiol 7:326. https://doi.org/10.3389/fmicb.2016.00326.
55. Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, Ziraldo SB, Wheeler TD, McDermott GP, Zhu J, Gregory MT, Shuga J, Montesclaros L, Underwood JG, Masquelier DA, Nishimura SY, Schnall-Levin M, Wyatt PW, Hindson CM, Bharadwaj R, Wong A, Ness KD, Beppu LW, Deeg HJ, McFarland C, Loeb KR, Valente WJ, Ericson NG, Stevens EA, Radich JP, Mikkelsen TS, Hindson BL, Bielas JH. 2017. Massively parallel digital transcriptional profiling of single cells. Nat Commun 8:14049. https://doi.org/10.1038/ncomms14049.
56. Robertson J, Schubert M, Lazzarini R. 1981. Polyadenylation sites for influenza virus mRNA. J Virol 38:157–163.
57. Koppstein D, Ashour J, Bartel DP. 2015. Sequencing the cap-snatching repertoire of H1N1 influenza provides insight into the mechanism of viral transcription initiation. Nucleic Acids Res 43:5052–5064. https://doi.org/10.1093/nar/gkv333.
58. Travers KJ, Chin CS, Rank DR, Eid JS, Turner SW. 2010. A flexible and efficient template format for circular consensus sequencing and SNP detection. Nucleic Acids Res 38:e159. https://doi.org/10.1093/nar/ gkq543.
59. Bloom JD. 2018. Estimating the frequency of multiplets in single-cell RNA sequencing from cell-mixing experiments. PeerJ 6:e5578. https://doi.org/10.7717/peerj.5578.
60. Haque A, Engel J, Teichmann SA, Lonnberg T. 2017. A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications. Genome Med 9:75. https://doi.org/10.1186/s13073-017-0467-4.
61. Dou D, Hernandez-Neuta I, Wang H, Ostbye H, Qian X, Thiele S, Resa-Infante P, Kouassi NM, Sender V, Hentrich K, Mellroth P, Henriques-Normark B, Gabriel G, Nilsson M, Daniels R. 2017. Analysis of IAV replication and co-infection dynamics by a versatile RNA viral genome labeling method. Cell Rep 20:251–263. https://doi.org/10.1016/j.celrep .2017.06.021.
62. Jacobs NT, Onuoha NO, Antia A, Antia R, Steel J, Lowen AC. 2019. Incomplete influenza A virus genomes are abundant but readily complemented during spatially structured viral spread. bioRxiv https://doi.org/10.1101/529065.
63. Hatada E, Hasegawa M, Mukaigawa J, Shimizu K, Fukuda R. 1989. Control of influenza virus gene expression: quantitative analysis of each viral RNA species in infected cells. J Biochem 105:537–546. https://doi.org/10.1093/oxfordjournals.jbchem.a122702.
64. Aguilera ER, Erickson AK, Jesudhasan PR, Robinson CM, Pfeiffer JK. 2017. Plaques formed by mutagenized viral populations have elevated coinfection frequencies. mBio 8:e02020-16. https://doi.org/10.1128/mBio.02020-16.
65. Combe M, Garijo R, Geller R, Cuevas JM, Sanjuan R. 2015. Single-cell analysis of RNA virus infection identifies multiple genetically diverse viral genomes within single infectious units. Cell Host Microbe 18:424 – 432. https://doi.org/10.1016/j.chom.2015.09.009.
66. Dhir A, Dhir S, Borowski LS, Jimenez L, Teitell M, Rotig A, Crow YJ, Rice GI, Duffy D, Tamby C, Nojima T, Munnich A, Schiff M, de Almeida CR, Rehwinkel J, Dziembowski A, Szczesny RJ, Proudfoot NJ. 2018. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560:238 –242. https://doi.org/10.1038/s41586-018-0363-0.
67. Benitez AA, Panis M, Xue J, Varble A, Shim JV, Frick AL, Lopez CB, Sachs D, tenOever BR. 2015. In vivo RNAi screening identifies MDA5 as a significant contributor to the cellular defense against influenza A virus. Cell Rep 11:1714–1726. https://doi.org/10.1016/j.celrep.2015.05.032.
68. Chiang JJ, Sparrer KMJ, van Gent M, Lässig C, Huang T, Osterrieder N, Hopfner K-P, Gack MU. 2018. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat Immunol 19: 53–62. https://doi.org/10.1038/s41590-017-0005-y.
69. Maaten L, Hinton G. 2008. Visualizing data using t-SNE. J Mach Learn Res 9:2579–2605.
70. Xu H, DiCarlo J, Satya RV, Peng Q, Wang Y. 2014. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data. BMC Genomics 15:244. https://doi.org/10.1186/1471-2164-15-244.
71. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, Getz G. 2013. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31:213–222. https://doi.org/10.1038/nbt.2514.
72. Gini C. 1921. Measurement of inequality of incomes. Econ J (London) 31:124–126. https://doi.org/10.2307/2223319.
73. Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y. 2003. Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A 100:2002–2007. https://doi.org/10.1073/pnas.0437772100.
74. Marsh GA, Hatami R, Palese P. 2007. Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. J Virol 81:9727–9736. https://doi.org/10.1128/JVI.01144-07.
75. Zhu Y, Yongky A, Yin J. 2009. Growth of an RNA virus in single cells reveals a broad fitness distribution. Virology 385:39–46. https://doi.org/10.1016/j.virol.2008.10.031.
76. Schulte M, Andino R. 2014. Single-cell analysis uncovers extensive biological noise in poliovirus replication. J Virol 88:6205–6212. https://doi.org/10.1128/JVI.03539-13.
77. Akpinar F, Timm A, Yin J. 2016. High-throughput single-cell kinetics of virus infections in the presence of defective interfering particles. J Virol 90:1599–1612. https://doi.org/10.1128/JVI.02190-15.
78. Gupta I, Collier PG, Haase B, Mahfouz A, Joglekar A, Floyd T, Koopmans F, Barres B, Smit AB, Sloan SA, Luo W, Fedrigo O, Ross ME, Tilgner HU. 2018. Single-cell isoform RNA sequencing characterizes isoforms in thousands of cerebellar cells. Nat Biotechnol 36:1197–1202. https://doi.org/10.1038/nbt.4259.
79. O’Connell RM, Balazs AB, Rao DS, Kivork C, Yang L, Baltimore D. 2010. Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS One 5:e12009. https://doi.org/10.1371/journal.pone.0012009.
80. Kim JH, Lee SR, Li LH, Park HJ, Park JH, Lee KY, Kim MK, Shin BA, Choi SY. 2011. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 6:e18556. https://doi.org/10.1371/journal.pone.0018556.
81. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493–497. https://doi.org/10.1093/oxfordjournals.aje.a118408.
82. Doud MB, Hensley SE, Bloom JD. 2017. Complete mapping of viral escape from neutralizing antibodies. PLoS Pathog 13:e1006271. https://doi.org/10.1371/journal.ppat.1006271.
83. Boers SA, Hays JP, Jansen R. 2015. Micelle PCR reduces chimera formation in 16S rRNA profiling of complex microbial DNA mixtures. Sci Rep 5:14181. https://doi.org/10.1038/srep14181.
84. Killip MJ, Smith M, Jackson D, Randall RE. 2014. Activation of the interferon induction cascade by influenza A viruses requires viral RNA synthesis and nuclear export. J Virol 88:3942–3952. https://doi.org/10.1128/JVI.03109-13.
85. Hirst GK. 1942. The quantitative determination of influenza virus and antibodies by means of red cell agglutination. J Exp Med 75:49–64. https://doi.org/10.1084/jem.75.1.49.
86. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272–1275. https://doi.org/10.1126/science.1187816.
87. Koster J, Rahmann S. 2012. Snakemake–a scalable bioinformatics workflow engine. Bioinformatics 28:2520–2522. https://doi.org/10.1093/bioinformatics/ bts480.
88. Li H. 2018. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34:3094–3100. https://doi.org/10.1093/bioinformatics/bty191.
89. Bloom JD. 2015. Software for the analysis and visualization of deep mutational scanning data. BMC Bioinformatics 16:168. https://doi.org/10.1186/s12859-015-0590-4.
90. Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T, Gottardo R, Hahne F, Hansen KD, Irizarry RA, Lawrence M, Love MI, MacDonald J, Obenchain V, Oles´ AK, Pagès H, Reyes A, Shannon P, Smyth GK, Tenenbaum D, Waldron L, Morgan M. 2015. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods 12:115. https://doi.org/10.1038/nmeth.3252.
91. Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C. 2017. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods 14:979. https://doi.org/10.1038/nmeth.4402.
92. Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL. 2014. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol 32:381. https://doi.org/10.1038/nbt.2859.
93. Reich S, Guilligay D, Pflug A, Malet H, Berger I, Crepin T, Hart D, Lunardi T, Nanao M, Ruigrok RW, Cusack S. 2014. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature 516: 361–366. https://doi.org/10.1038/nature14009.
94. Reich S, Guilligay D, Cusack S. 2017. An in vitro fluorescence based study of initiation of RNA synthesis by influenza B polymerase. Nucleic Acids Res 45:3353–3368. https://doi.org/10.1093/nar/gkx043.
95. Fodor E, Crow M, Mingay LJ, Deng T, Sharps J, Fechter P, Brownlee GG. 2002. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J Virol 76:8989–9001. https://doi.org/10.1128/JVI.76.18.8989-9001.2002.
96. Vreede FT, Jung TE, Brownlee GG. 2004. Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates. J Virol 78:9568–9572. https://doi.org/10.1128/JVI.78.17.9568-9572.2004.
97. Velthuis A. t, Robb NC, Kapanidis AN, Fodor E. 2016. The role of the priming loop in influenza A virus RNA synthesis. Nat Microbiol 1:16029. https://doi.org/10.1038/nmicrobiol.2016.29.